ReviewThe plant genome2025
Benefits, concerns, and sustainable alternatives to genetically modified crops from a global and Indian perspective.
Review in The plant genome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Risk governance of transgenic plants: bridging science, policy, and public trust.Transgenic research · 2026Review
- Beyond GMOs: transgene-free gene-edited crops for global food security.Frontiers in plant science · 2026Review
- Benefits, concerns, and sustainable alternatives to genetically modified crops from a global and Indian perspective.The plant genome · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global population, set to exceed 10 billion by 2050, presents enormous challenges to food, health, nutrition, energy, and environmental security. Plant breeding methods have continuously evolved to develop improved crop varieties to meet these demands. Among the recent developments, genetically modified crops (GMCs) have emerged as a viable option to enhance crop yields, nutritional value, biofuel potential, and climatic adaptability. However, extensive application of GMCs is a very controversial subject due to biosafety issues, environmental impacts, economic viability, and legal considerations. This review presents a critical evaluation of the merits and limitations of GMCs, along with a discussion of available alternative approaches, with particular reference to the Indian context. While GMCs have been developed with increased yields, improved shelf life, reduced pesticide and herbicide use, and improved stress tolerance, potential risks such as health hazards and socioeconomic impacts on smallholding farmers in the developing world cannot be disregarded. Besides, regulatory policies and public perception have a significant influence on the acceptability and commercialization of GMCs, especially in countries like India. The discussion therefore encompasses other sustainable alternatives, including marker-assisted selection, genomics-aided breeding, cisgenesis, intragenesis, and stringently regulated gene editing, that embody environment-friendly approaches to agricultural enhancement. A collective assessment of these techniques is presented in order to examine their prospects for delivering long-term biosecurity without compromising environmental and human health. By integrating scientific advances, policy environments, and social perceptions, this review aims to present a balanced perspective of GMCs and their role in the future of global agriculture, particularly in the Global South.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.